|
|
 |
 |
| |
 Printable version |
Eczema molluscatum in tacrolimus treated atopic dermatitis |
European Journal of Dermatology. Volume 14, Number 1, 73-4, January-February 2004, Clinical report
|
 Free Article
|
Author(s) : Stefanie WETZEL, Andreas WOLLENBERG |
Summary : Eczema molluscatum describes the occurrence of
molluscum contagiosum virus infection in a patient with underlying atopic dermatitis. Novel, safe and effective treatment options in atopic dermatitis are the topical immunomodulators tacrolimus and pimecrolimus. One major advantage over corticosteroids is that they do not induce skin atrophy. Some physicians fear that topical immunomodulators may predispose patients to skin infections. We observed a patient with atopic dermatitis who developed eczema molluscatum during treatment with tacrolimus 0.1% ointment. After withdrawal of tacrolimus, the lesions resolved spontaneously over 3 weeks. |
Keywords : atopic dermatitis, eczema molluscatum, tacrolimus |
|
